India Makes High-Value Drugs Under PLI Scheme, Investment Almost Double The Promised Amount: Govt To House Panel

The top five recipients of incentives include Aurobindo Pharma, Cipla, Dr Reddy’s, Glenmark and Sun Pharma, while the claim amount ranges from Rs 150 crore to Rs 330 crore